|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Revenue: | |||
| Operating expenses: | |||
| Cost of sales | |||
| Sales and marketing | |||
| Product development | |||
| General and administrative | |||
| Impairment of intangible and fixed assets | |||
| Amortization of intangible assets | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense): | |||
| Interest expense, net | |||
| Change in fair value of bifurcated embedded derivatives | |||
| Other expense | |||
| Total other expense, net | |||
| Total loss before income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Net loss per share – basic and diluted (in dollars per share) | |||
| Weighted average common shares – basic and diluted (in shares) |
Loading...